Bronchitol 40 mg, inhalation powder, hard capsules
- Name:
Bronchitol 40 mg, inhalation powder, hard capsules
- Company:
Pharmaxis Europe Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 14/01/21
(Click to Download)Click on this link to Download PDF directly
Pharmaxis Europe Limited
Company Products
| Medicine Name | Active Ingredients |
|---|---|
| Medicine Name Bronchitol 40 mg, inhalation powder, hard capsules | Active Ingredients Mannitol |
| Medicine Name Osmohale Inhalation Powder, Hard Capsule | Active Ingredients Mannitol |
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 14 January 2021 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
- Change of distributor details
Free text change information supplied by the pharmaceutical company
Update to Distributor details for Ireland and update to Section 4 How to report a side effect
Updated on 14 October 2020 PIL
Reasons for updating
- Change in co-marketing arrangement
Updated on 21 January 2020 PIL
Reasons for updating
- Change in co-marketing arrangement
Updated on 10 April 2019 PIL
Reasons for updating
- Change to section 4 - possible side effects
Updated on 10 April 2019 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 30 January 2019 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 30 January 2019 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Update of Marketing Authorisation Holder
Updated on 7 June 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 7 June 2017 PIL
Reasons for updating
- Change to section 6 - manufacturer
Updated on 30 January 2017 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - use in children/adolescents
- Change to section 3 - how to take/use
- Change to section 6 - what the product looks like and pack contents
Updated on 29 January 2017 SPC
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.8 - Undesirable effects
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 6.4 - Special precautions for storage
- Change to section 6.5 - Nature and contents of container
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 29 January 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 19 April 2016 PIL
Reasons for updating
- Removal/change of distributor
Updated on 5 April 2016 SPC
Reasons for updating
- Change to section 6.4 - Special precautions for storage
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 4 April 2016 PIL
Reasons for updating
- Change to storage instructions
Updated on 28 January 2016 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 7 October 2015 PIL
Reasons for updating
- New PIL for medicines.ie